Friday, June 18th, 2010
The top issue vexing pharmaceutical executives is the changing commercial business model, according to "2010 Pharma Insights," a new report from Cegedim Dendrite. The pharma CRM and data solutions company conducted an online survey of 211 pharmaceutical executives in North and South America. Thirty-five percent of surveyed executives cited the ...
Posted in
DTC advertising, Economy, Pharmaceutical operations, Sales & Marketing, Sales force effectiveness, Social media in pharma, Technology |
No Comments »
Thursday, April 22nd, 2010
Tonight, following the 21st Annual Manny Awards honoring outstanding acheivements in healthcare advertising, our April issue will be unveiled along with all the winners. Meanwhile, our May issue, including one of our regular features on promotional medical education, is in full production.
For last year’s promotional medical education feature, I had ...
Posted in
Behind the scenes, Legal actions, Manny Awards, Promotional medical education, Sales & Marketing |
1 Comment »
Tuesday, January 19th, 2010
A 9-year-old boy obsesses over his mayoral approval rating within the online world of Sim City 2000. A 13-year-old girl misses dinner to attend a board meeting as her World of Warcraft compatriots debate the merits of a guild merger. Speaking today at a panel discussion hosted by ProtonMedia and ...
Posted in
Economy, Pharma Business, Pharmaceutical operations, Professional education, Sales force effectiveness, Technology, e-Marketing |
3 Comments »
Tuesday, February 24th, 2009
Watching the Oscars a night late loses a lot of the drama, but on the plus side, you can fast forward through the musical numbers. This year’s telecast didn’t hold a whole lot of interest for me anyway due to what I found to be a lackluster line up of ...
Posted in
Pharma Business |
No Comments »
Tuesday, February 10th, 2009
In a recent op-ed in The Seattle Times, James Bianco, M.D., CEO of Cell Therapeutics Inc., talks about how his company was able to raise $117 million in 2008 through innovative, but dilutive, financing, despite public-company financing being down 58% from 2007. According to Dr. Bianco, the worst mistake a ...
Posted in
Med Ad News |
No Comments »
Friday, January 30th, 2009
Bill Cooney of MedPoint Communications, another frequent contributor to Med Ad News, has shared with us some of his thoughts on Pfizer's planned acquisition of Wyeth.
The Pfizer/Wyeth deal is not only a milestone on its own merits, but it’s even more important as the opening bell for an historic round ...
Posted in
Pharma Business |
1 Comment »
Monday, January 26th, 2009
Mike Luby, co-founder, TargetRx, is a frequent contributor to Med Ad News. I have always found his perspective, as a long-time industry observer, to be invaluable. I asked him to offer his take on Pfizer’s plan to acquire Wyeth, particularly from a sales and marketing perspective.
Does Wyeth offer any marketing ...
Posted in
Pharma Business |
No Comments »
Monday, January 26th, 2009
So, the numbers are in. CNN reports that Pfizer is planning two waves of job cuts for 2009, first cutting 10% of its 81,900 staff. The second round of cuts will take place after the merger with Wyeth is completed in the third or fourth quarter. This is expected to ...
Posted in
Pharma Business |
No Comments »
Monday, January 26th, 2009
The fourth quarter of 2008 was bleak for Pfizer, which was destined to lose its industry-leading position within the next five years. With the planned acquisition of Wyeth, however, Pfizer should stay on top a while longer.
For the fourth quarter , Pfizer posted reported net income of $266 million, a ...
Posted in
Pharma Business |
No Comments »
Monday, January 26th, 2009
Back in February of 2007, I wrote an article in Med Ad News about the history and potential drawbacks of pharmaceutical megamergers ("For richer or poorer"). This past weekend brought the latest chapter in that saga, with the board of Wyeth accepting a $68 billion cash/stock acquisition offer from Pfizer. ...
Posted in
Pharma Business |
1 Comment »
|
|
